Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stuart Therapeutics, Inc.

Latest From Stuart Therapeutics, Inc.

Asia Deal Watch: Astellas Begins 2023 Signing Rare Disease Tie-Ups With Selecta, Twist

Evopoint and Kaken also ring in the new year with multiple deals. Biocytogen licenses antibodies against a specified target derived from its RenMice platform technology to Hansoh Pharma.

Deal Watch Business Strategies

Big Companies are from Mars, Small Companies from Venus

A review of the Phoenix '97 CEO conference shows there's a long way to go in bridging the communication gap between large and small companies.

Medical Device Strategy

Owens & Minor -- The Economics of 'Just Say No'

Back from the brink of financial disaster, distributors are getting healthy with a strategy that draws limits around what they can do for customers and suppliers.

Medical Device

Bristol-Myers Squibb: Building Billion-Dollar Device Businesses

Focusing on franchises not individual products, BMS is developing strategies for its Zimmer and ConvaTec divisions that enable them to grow at once independently and synergistically. BMS is exploring potential links between its various businesses which capitalize on new market or technology opportunities without sacrificing the skills that made each company successful.

Medical Device Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Other Names / Subsidiaries
    • Stuart Medical Inc.